Ping Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ping Liu has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Xianwei Huang
Department of Emergency, The First Affiliated Hospital of Xiamen University, Fujian, China
8 shared publicationsJiayu Wang
Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin, 300211, China
7 shared publicationsCaihua Fu
Department of Cardiology, Jinan Central Hospital Affiliated Shandong University, Jinan, China
6 shared publicationsYixuan Liu
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
6 shared publicationsPeiqing Tian
Department of Cardiology, The Qilu Second Hospital of Shandong University, Shandong, 250033, China
5 shared publicationsJuan Meng
Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong, China
4 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Springer Nature in Journal of Health, Population and Nutrition
Changes in frailty and incident circadian syndrome in middle-aged and older adults: a nationwide prospective cohort study
- 8 September 2026
- Published by Springer Nature in Journal of Health, Population and Nutrition
Open AccessChanges in frailty and incident circadian syndrome in middle-aged and older adults: a nationwide prospective cohort study
- Open Access
- 1 August 2026
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 19, 1-17
CircEif3c/miR-96–5p/PHF20L1/MEOX2 axis in perivascular preadipocyte exosomes mediates fibroblast dysfunction and vascular remodeling
Diabetes mellitus is a major modifiable risk factor for atherosclerotic cardiovascular disease and pathological vascular remodeling. During chronic hyperglycemia, exosomes serve as essential nanocarriers that coordinate intercellular communication and induce structural and functional alterations in the vascular wall. Perivascular pre-adipocytes (PVPACs) exhibit high exosome secretory activity, while adventitial fibroblasts (AFs) are key effector cells in vascular remodeling. Despite their anatomical proximity, the potential bidirectional crosstalk between PVPAC-derived exosomes and AFs, and its roles for vascular remodeling, remains largely unexplored. A co-culture system of PVPACs and AFs, along with a mouse model of perivascular proliferation, was established under sustained hyperglycemic conditions. Exosomes were isolated via sequential ultracentrifugation and characterized based on morphology, size distribution, and exosomal markers. High-throughput RNA microarray was employed to profile PVPAC-derived exosomal RNAs, with qRT-PCR and in situ hybridization used to validate the expression of circEif3c, miR-96–5p, PHF20L1, and MEOX2. Mechanistic studies integrated bioinformatic predictions, CRISPR-Cas9 editing, with bio-functional assays, including RNA pull-down, RIP, dual-luciferase reporter, CO-IP, and protein interaction analyses, to elucidate the circEif3c/miR-96–5p/PHF20L1/MEOX2 axis. In vitro and in vivo rescue experiments evaluated the role of exosomal circEif3c in AF proliferation, migration, apoptosis, and vascular remodeling. PVPAC-derived exosomes were enriched with circEif3c, which acted as a competitive endogenous RNA by sequestering miR-96–5p, thus alleviating its suppression of PHF20L1 and inhibiting MEOX2 signaling. This axis enhanced AF proliferation and migration, reduced apoptosis, and exacerbated vascular remodeling. Conversely, inhibition of exosomal circEif3c or overexpression of MEOX2 attenuated AF activation, promoted apoptosis, and markedly improved vascular remodeling in diabetic mice. Our findings establish the PVPAC-derived exosomal circEif3c/miR-96–5p/PHF20L1/MEOX2 axis as a critical driver of hyperglycemia-induced vascular remodeling. Targeting this pathway presents a promising therapeutic strategy to combat diabetes-associated vascular pathology and its complications.
- 1 August 2026
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 19, 1-17
Open AccessCircEif3c/miR-96–5p/PHF20L1/MEOX2 axis in perivascular preadipocyte exosomes mediates fibroblast dysfunction and vascular remodeling
Diabetes mellitus is a major modifiable risk factor for atherosclerotic cardiovascular disease and pathological vascular remodeling. During chronic hyperglycemia, exosomes serve as essential nanocarriers that coordinate intercellular communication and induce structural and functional alterations in the vascular wall. Perivascular pre-adipocytes (PVPACs) exhibit high exosome secretory activity, while adventitial fibroblasts (AFs) are key effector cells in vascular remodeling. Despite their anatomical proximity, the potential bidirectional crosstalk between PVPAC-derived exosomes and AFs, and its roles for vascular remodeling, remains largely unexplored. A co-culture system of PVPACs and AFs, along with a mouse model of perivascular proliferation, was established under sustained hyperglycemic conditions. Exosomes were isolated via sequential ultracentrifugation and characterized based on morphology, size distribution, and exosomal markers. High-throughput RNA microarray was employed to profile PVPAC-derived exosomal RNAs, with qRT-PCR and in situ hybridization used to validate the expression of circEif3c, miR-96–5p, PHF20L1, and MEOX2. Mechanistic studies integrated bioinformatic predictions, CRISPR-Cas9 editing, with bio-functional assays, including RNA pull-down, RIP, dual-luciferase reporter, CO-IP, and protein interaction analyses, to elucidate the circEif3c/miR-96–5p/PHF20L1/MEOX2 axis. In vitro and in vivo rescue experiments evaluated the role of exosomal circEif3c in AF proliferation, migration, apoptosis, and vascular remodeling. PVPAC-derived exosomes were enriched with circEif3c, which acted as a competitive endogenous RNA by sequestering miR-96–5p, thus alleviating its suppression of PHF20L1 and inhibiting MEOX2 signaling. This axis enhanced AF proliferation and migration, reduced apoptosis, and exacerbated vascular remodeling. Conversely, inhibition of exosomal circEif3c or overexpression of MEOX2 attenuated AF activation, promoted apoptosis, and markedly improved vascular remodeling in diabetic mice. Our findings establish the PVPAC-derived exosomal circEif3c/miR-96–5p/PHF20L1/MEOX2 axis as a critical driver of hyperglycemia-induced vascular remodeling. Targeting this pathway presents a promising therapeutic strategy to combat diabetes-associated vascular pathology and its complications.
- Open Access
- 5 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Predictive values of neck circumference and TyG index on polycystic ovary syndrome with metabolic syndrome
We aimed to explore the factors affecting polycystic ovary syndrome (PCOS) with metabolic syndrome (MetS) in Chinese women of reproductive age, and to evaluate the predictive value of neck circumference (NC), TyG index, and other composite indexes. A retrospective analysis was performed on 517 patients admitted to the Second Hospital of Shandong University and Qilu Hospital of Shandong University from January 2017 to January 2024. The research included 150 normal control cases (29.01%), 175 PCOS cases (33.85%), and 192 PCOS + MetS cases (37.14%). Anthropometric indices, blood pressure, and biochemical parameters such as blood glucose, blood lipids, and related hormones were detected. ANOVA, multi-factor logistic regression analysis and ROC curve prediction analysis were performed. The adjusted odds ratios (OR) for PCOS + MetS predicted by NC and TyG were 3.516 (95%CI 1.910, 6.742) and 3.386 (95%CI 2.013, 6.208), respectively (all P < 0.05). ROC curve analysis identified optimal cut-off values of 35.9 cm for NC (sensitivity 84.8%, specificity 72%, P < 0.05) and 9.04 for TyG index (sensitivity 89.6%, specificity 65.5%, P < 0.05), respectively. Our study suggests NC and TyG are significant predictors for PCOS + MetS, and compared to TyG index, NC is more convenient, intuitive, economical, and practical.
- 5 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessPredictive values of neck circumference and TyG index on polycystic ovary syndrome with metabolic syndrome
We aimed to explore the factors affecting polycystic ovary syndrome (PCOS) with metabolic syndrome (MetS) in Chinese women of reproductive age, and to evaluate the predictive value of neck circumference (NC), TyG index, and other composite indexes. A retrospective analysis was performed on 517 patients admitted to the Second Hospital of Shandong University and Qilu Hospital of Shandong University from January 2017 to January 2024. The research included 150 normal control cases (29.01%), 175 PCOS cases (33.85%), and 192 PCOS + MetS cases (37.14%). Anthropometric indices, blood pressure, and biochemical parameters such as blood glucose, blood lipids, and related hormones were detected. ANOVA, multi-factor logistic regression analysis and ROC curve prediction analysis were performed. The adjusted odds ratios (OR) for PCOS + MetS predicted by NC and TyG were 3.516 (95%CI 1.910, 6.742) and 3.386 (95%CI 2.013, 6.208), respectively (all P < 0.05). ROC curve analysis identified optimal cut-off values of 35.9 cm for NC (sensitivity 84.8%, specificity 72%, P < 0.05) and 9.04 for TyG index (sensitivity 89.6%, specificity 65.5%, P < 0.05), respectively. Our study suggests NC and TyG are significant predictors for PCOS + MetS, and compared to TyG index, NC is more convenient, intuitive, economical, and practical.
- Open Access
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (6) , C1611-C1624
Sodium-glucose cotransporter 1 promotes the biofunctions of perivascular preadipocytes mediated by Akt/mTOR/p70S6K signaling pathway
SGLT-1 is expressed in PVPACs and can affect preadipocyte glucolipid metabolism and vascular remodeling. SGLT-1 promotes the biofunctions of PVPACs mediated by Akt/mTOR/p70S6K signaling pathway. Compared with caudal vein or intraperitoneal injection, the external application of lentivirus-based thermal gel around the carotid artery is an innovative attempt at vascular remodeling model, it may effectively avoid the transfection of lentiviral vector into the whole body of mice and the adverse effect on experimental results.
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (6) , C1611-C1624
Open AccessSodium-glucose cotransporter 1 promotes the biofunctions of perivascular preadipocytes mediated by Akt/mTOR/p70S6K signaling pathway
SGLT-1 is expressed in PVPACs and can affect preadipocyte glucolipid metabolism and vascular remodeling. SGLT-1 promotes the biofunctions of PVPACs mediated by Akt/mTOR/p70S6K signaling pathway. Compared with caudal vein or intraperitoneal injection, the external application of lentivirus-based thermal gel around the carotid artery is an innovative attempt at vascular remodeling model, it may effectively avoid the transfection of lentiviral vector into the whole body of mice and the adverse effect on experimental results.
- Open Access
- 11 December 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1277427
Exosomal circSCMH1/miR-874 ratio in serum to predict carotid and coronary plaque stability
Background: To investigate the correlation between lg (circSCMH1/miR-874) and acute coronary syndrome (ACS), acute myocardial infarction (AMI), and carotid plaque stability.Methods: 701 patients were divided into stable coronary artery disease (SCAD), ACS, and control groups. Furthermore, 225 patients who underwent carotid ultrasound were selected from the above 701 patients and were divided into low-risk plaque, medium-to-high risk plaque, and control (without carotid plaques) groups. We collected their baseline characteristics and measured the contents of exosomal circSCMH1 and miR-874 in peripheral blood. Then lg(circSCMH1/miR-874) was calculated and statistical analysis was performed.Results: The lg (circSCMH1/miR-874) values of ACS, SCAD, and the control group decreased successively (P < 0.05). Compared with the low-risk plaque and control groups, the lg (circSCMH1/miR-874) value of medium-high risk plaque group decreased (P < 0.05). Multivariate logistic regression analysis showed that with the decrease of lg (circSCMH1/miR-874), the risk of ACS, AMI, and medium-high risk plaques increased. ROC curve analysis demonstrated that lg (circSCMH1/miR-874) has a higher diagnostic value for ACS, AMI and medium-high risk plaques than previously used predictive ratios.Conclusion: Lg (circSCMH1/miR-874) is closely associated with coronary and carotid plaque stability.
- 11 December 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1277427
Open AccessExosomal circSCMH1/miR-874 ratio in serum to predict carotid and coronary plaque stability
Background: To investigate the correlation between lg (circSCMH1/miR-874) and acute coronary syndrome (ACS), acute myocardial infarction (AMI), and carotid plaque stability.Methods: 701 patients were divided into stable coronary artery disease (SCAD), ACS, and control groups. Furthermore, 225 patients who underwent carotid ultrasound were selected from the above 701 patients and were divided into low-risk plaque, medium-to-high risk plaque, and control (without carotid plaques) groups. We collected their baseline characteristics and measured the contents of exosomal circSCMH1 and miR-874 in peripheral blood. Then lg(circSCMH1/miR-874) was calculated and statistical analysis was performed.Results: The lg (circSCMH1/miR-874) values of ACS, SCAD, and the control group decreased successively (P < 0.05). Compared with the low-risk plaque and control groups, the lg (circSCMH1/miR-874) value of medium-high risk plaque group decreased (P < 0.05). Multivariate logistic regression analysis showed that with the decrease of lg (circSCMH1/miR-874), the risk of ACS, AMI, and medium-high risk plaques increased. ROC curve analysis demonstrated that lg (circSCMH1/miR-874) has a higher diagnostic value for ACS, AMI and medium-high risk plaques than previously used predictive ratios.Conclusion: Lg (circSCMH1/miR-874) is closely associated with coronary and carotid plaque stability.
- Open Access
- 18 August 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (8) , 239
Psycho-Cardiological Disease in COVID-19 Era
During the coronavirus disease 2019 (COVID-19) pandemic, panic and public health responses, including self-monitored quarantine and lockdown of the city, have severely impacted mental health and caused depression or anxiety in citizens. Psycho-cardiology indicates that psychological factor plays an important role in coronary heart disease (CHD). COVID-19, depression and CHD can co-exist and deleteriously affect each other, leading to worse progression and prognosis. Delays in medical consultation and treatment have become more common than before the pandemic, inducing more cardiovascular (CV) events and sequelae. COVID-19 survivors have been identified to have more psycho-cardiological symptoms compared with non-COVID-19 controls. Undoubtedly, diet alterations and sedentary lifestyles during the pandemic will cause and aggravate psycho-cardiological diseases. Some frequently used cardiovascular drugs were found to associate with changes in depression. With the advent of the post-pandemic era, although the acute damage of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is gradually declining, the psycho-cardiological diseases related to the novel coronavirus are becoming increasingly prominent. So it is an important issue for us to explore the pathogenesis, clinical manifestations and corresponding preventive measures of this aspect.
- 18 August 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (8) , 239
Open AccessPsycho-Cardiological Disease in COVID-19 Era
During the coronavirus disease 2019 (COVID-19) pandemic, panic and public health responses, including self-monitored quarantine and lockdown of the city, have severely impacted mental health and caused depression or anxiety in citizens. Psycho-cardiology indicates that psychological factor plays an important role in coronary heart disease (CHD). COVID-19, depression and CHD can co-exist and deleteriously affect each other, leading to worse progression and prognosis. Delays in medical consultation and treatment have become more common than before the pandemic, inducing more cardiovascular (CV) events and sequelae. COVID-19 survivors have been identified to have more psycho-cardiological symptoms compared with non-COVID-19 controls. Undoubtedly, diet alterations and sedentary lifestyles during the pandemic will cause and aggravate psycho-cardiological diseases. Some frequently used cardiovascular drugs were found to associate with changes in depression. With the advent of the post-pandemic era, although the acute damage of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is gradually declining, the psycho-cardiological diseases related to the novel coronavirus are becoming increasingly prominent. So it is an important issue for us to explore the pathogenesis, clinical manifestations and corresponding preventive measures of this aspect.
- Open Access
- 18 August 2023
- Published by Elsevier in Atherosclerosis
- Vol. 394, 117242
Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes
- 18 August 2023
- Published by Elsevier in Atherosclerosis
- Vol. 394, 117242
Open AccessCorrelation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes
- Open Access
- 16 November 2022
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 123 (03) , 347-361
Genetic Predisposition of Both Waist Circumference and Hip Circumference Increased the Risk of Venous Thromboembolism
Background Obesity, especially abdominal obesity, is an independent indicator of increased cardiovascular risk. Observational studies have shown an observational association between obesity and venous thromboembolism (VTE). As a type of VTE, pulmonary embolism (PE) is also associated with obesity. However, it is unclear whether the observed associations are causal or caused by confounding bias or reverse causality. Methods We performed a two-sample test by obtaining the exposure dataset of waist circumference (WC) and hip circumference (HC) from the Neale Laboratory Consortium's genome-wide association study summary data and the summary-level outcome data of VTE and PE from FinnGen Biobank of European ancestry to determine the causal effect of WC and HC on VTE and PE. Results All three Mendelian randomization methods displayed a positive association between WC/HC and VTE/PE. WC and HC were positively associated with VTE (odds ratio [OR] = 1.803 per 1 standard deviation [SD] increase in WC, 95% confidence interval [CI] = 1.393–2.333; p < 0.001; OR = 1.479 per 1 SD increase in HC, 95% CI = 1.219–1.796; p < 0.001, respectively). Furthermore, we found a causal association between genetically predicted WC/HC and a higher risk of PE (OR = 1.929 per 1 SD increase in WC, 95% CI = 1.339–2.778, p < 0.001; OR = 1.431 per 1 SD increase in HC, 95% CI =1.095–1.869; p = 0.009, respectively). Conclusion There is a significant causal relationship between WC/HC and VTE/PE, which is consistent with observational studies. Taking measures to reduce WC/HC of obesity may help reduce the incidence of VTE/PE. Obesity, especially abdominal obesity, is an independent indicator of increased cardiovascular risk. There have been observational studies that showed an observational association between obesity and venous thromboembolism. As a type of venous thromboembolism, pulmonary embolism is also associated with obesity. But it is unclear whether the observed association is causal or caused by confounding bias or reverse causality. To verify and compare the effects of waist circumstance and hip circumstance on venous thromboembolism and life-threatening pulmonary embolism, we used the method of Mendelian randomization study to analysis the exposure data from the Neale Laboratory Consortium's GWAS summary data and the summary-level outcome data from FinnGen Biobank of European ancestry. Then we found a causal association between genetically predicted waist circumstance/hip circumstance and higher risk of pulmonary embolism, and compared with hip circumstance, waist circumstance is a better anthropometric index to predict venous thromboembolism in obese patients. This conclusion is consistent with observational studies. But compared with observational studies, our findings provide evidence of significant causality between waist circumstance/hip circumstance and venous thromboembolism/pulmonary embolism. Based on the above conclusions, we make the case that taking measures to reduce waist circumstance/hip circumstance of obesity may help reduce the incidence of venous thromboembolism. Project design and interpretation: J.T. and P.L.; data curation: J.T. and J.W.; statistical analysis: J.T.; methodology: J.T. and P.L.; validation: P.L., Q.S., and X.H.; writing—original draft: J.T. and J.W.; review, revision, and editing: P.L., J.T., and L.H. All authors have read and agreed to the published version of the manuscript. * These authors have contributed equally to this work and share authorship. Received: 25 June 2022 Accepted: 11 November 2022 Accepted Manuscript online: 16 November 2022 Article published online: 05 January 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 16 November 2022
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 123 (03) , 347-361
Open AccessGenetic Predisposition of Both Waist Circumference and Hip Circumference Increased the Risk of Venous Thromboembolism
Background Obesity, especially abdominal obesity, is an independent indicator of increased cardiovascular risk. Observational studies have shown an observational association between obesity and venous thromboembolism (VTE). As a type of VTE, pulmonary embolism (PE) is also associated with obesity. However, it is unclear whether the observed associations are causal or caused by confounding bias or reverse causality. Methods We performed a two-sample test by obtaining the exposure dataset of waist circumference (WC) and hip circumference (HC) from the Neale Laboratory Consortium's genome-wide association study summary data and the summary-level outcome data of VTE and PE from FinnGen Biobank of European ancestry to determine the causal effect of WC and HC on VTE and PE. Results All three Mendelian randomization methods displayed a positive association between WC/HC and VTE/PE. WC and HC were positively associated with VTE (odds ratio [OR] = 1.803 per 1 standard deviation [SD] increase in WC, 95% confidence interval [CI] = 1.393–2.333; p < 0.001; OR = 1.479 per 1 SD increase in HC, 95% CI = 1.219–1.796; p < 0.001, respectively). Furthermore, we found a causal association between genetically predicted WC/HC and a higher risk of PE (OR = 1.929 per 1 SD increase in WC, 95% CI = 1.339–2.778, p < 0.001; OR = 1.431 per 1 SD increase in HC, 95% CI =1.095–1.869; p = 0.009, respectively). Conclusion There is a significant causal relationship between WC/HC and VTE/PE, which is consistent with observational studies. Taking measures to reduce WC/HC of obesity may help reduce the incidence of VTE/PE. Obesity, especially abdominal obesity, is an independent indicator of increased cardiovascular risk. There have been observational studies that showed an observational association between obesity and venous thromboembolism. As a type of venous thromboembolism, pulmonary embolism is also associated with obesity. But it is unclear whether the observed association is causal or caused by confounding bias or reverse causality. To verify and compare the effects of waist circumstance and hip circumstance on venous thromboembolism and life-threatening pulmonary embolism, we used the method of Mendelian randomization study to analysis the exposure data from the Neale Laboratory Consortium's GWAS summary data and the summary-level outcome data from FinnGen Biobank of European ancestry. Then we found a causal association between genetically predicted waist circumstance/hip circumstance and higher risk of pulmonary embolism, and compared with hip circumstance, waist circumstance is a better anthropometric index to predict venous thromboembolism in obese patients. This conclusion is consistent with observational studies. But compared with observational studies, our findings provide evidence of significant causality between waist circumstance/hip circumstance and venous thromboembolism/pulmonary embolism. Based on the above conclusions, we make the case that taking measures to reduce waist circumstance/hip circumstance of obesity may help reduce the incidence of venous thromboembolism. Project design and interpretation: J.T. and P.L.; data curation: J.T. and J.W.; statistical analysis: J.T.; methodology: J.T. and P.L.; validation: P.L., Q.S., and X.H.; writing—original draft: J.T. and J.W.; review, revision, and editing: P.L., J.T., and L.H. All authors have read and agreed to the published version of the manuscript. * These authors have contributed equally to this work and share authorship. Received: 25 June 2022 Accepted: 11 November 2022 Accepted Manuscript online: 16 November 2022 Article published online: 05 January 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 16 September 2022
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-18
Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome
Background: Multivessel coronary disease (MVCD) is the common type of coronary artery disease in acute coronary syndrome (ACS). Coronary artery calcification (CAC) has been confirmed the strong predictor of major adverse cardiovascular events (MACEs). Several studies have validated that triglyceride glucose (TyG) index can reflect the degree of coronary calcification or predict MACEs. However, no evidence to date has elucidated and compared the predictive intensity of TyG index or/and coronary artery calcification score (CACS) on multi-vascular disease and MACEs in ACS patients. Methods: A total of 935 patients, diagnosed with ACS and experienced coronary computed tomography angiography (CCTA) from August 2015 to March 2022 in the Second Hospital of Shandong University, were selected for retrospective analysis. The subjects were divided into TyG index quartile 1–4 groups (Q1-Q4 groups), non-multivessel coronary disease (non-MVCD) and multivessel coronary disease (MVCD) groups, respectively. The general data, past medical or medication history, laboratory indicators, cardiac color Doppler ultrasound, CACS, and TyG indexes were respectively compared among these groups. The ROC curve preliminarily calculated and analyzed the diagnostic value of TyG index, CACS, and the combination of the two indicators for MVCD. Univariate and multivariate logistic regression analysis discriminated the independent hazard factors for forecasting MVCD. Results: Compared with the lower TyG index and non-MVCD groups, the higher TyG index and MVCD groups had higher values of age, smoking history, waist circumference, systolic blood pressure, low-density lipoprotein cholesterol(LDL-C), fasting blood glucose and glycosylated hemoglobin, and CACS, but lower values of high-density lipoprotein cholesterol(HDL-C) (all P < 0.01). Coronary artery calcification is more common in the left anterior descending artery. Compared with non-MVCD, each unit increase in TyG index was associated with a 1.213-fold increased risk of MVCD. Logistic regression analysis adjusted for potential confounders indicated that TyG index is an independent risk factor for MVCD. With the increase of TyG index, the incidence of MACEs, apart from all-cause death, cardiac death, unexpected re-hospitalization of heart failure, recurrent ACS or unplanned revascularization, and non-fatal stroke in coronary artery increased (P log-rank < 0.001). Conclusion: TyG index could completely substitute for CACS as a reliable, practical, and independent indicator for predicting the severity and prognosis of MVCD in patients with ACS.
- 16 September 2022
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-18
Open AccessAssociation between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome
Background: Multivessel coronary disease (MVCD) is the common type of coronary artery disease in acute coronary syndrome (ACS). Coronary artery calcification (CAC) has been confirmed the strong predictor of major adverse cardiovascular events (MACEs). Several studies have validated that triglyceride glucose (TyG) index can reflect the degree of coronary calcification or predict MACEs. However, no evidence to date has elucidated and compared the predictive intensity of TyG index or/and coronary artery calcification score (CACS) on multi-vascular disease and MACEs in ACS patients. Methods: A total of 935 patients, diagnosed with ACS and experienced coronary computed tomography angiography (CCTA) from August 2015 to March 2022 in the Second Hospital of Shandong University, were selected for retrospective analysis. The subjects were divided into TyG index quartile 1–4 groups (Q1-Q4 groups), non-multivessel coronary disease (non-MVCD) and multivessel coronary disease (MVCD) groups, respectively. The general data, past medical or medication history, laboratory indicators, cardiac color Doppler ultrasound, CACS, and TyG indexes were respectively compared among these groups. The ROC curve preliminarily calculated and analyzed the diagnostic value of TyG index, CACS, and the combination of the two indicators for MVCD. Univariate and multivariate logistic regression analysis discriminated the independent hazard factors for forecasting MVCD. Results: Compared with the lower TyG index and non-MVCD groups, the higher TyG index and MVCD groups had higher values of age, smoking history, waist circumference, systolic blood pressure, low-density lipoprotein cholesterol(LDL-C), fasting blood glucose and glycosylated hemoglobin, and CACS, but lower values of high-density lipoprotein cholesterol(HDL-C) (all P < 0.01). Coronary artery calcification is more common in the left anterior descending artery. Compared with non-MVCD, each unit increase in TyG index was associated with a 1.213-fold increased risk of MVCD. Logistic regression analysis adjusted for potential confounders indicated that TyG index is an independent risk factor for MVCD. With the increase of TyG index, the incidence of MACEs, apart from all-cause death, cardiac death, unexpected re-hospitalization of heart failure, recurrent ACS or unplanned revascularization, and non-fatal stroke in coronary artery increased (P log-rank < 0.001). Conclusion: TyG index could completely substitute for CACS as a reliable, practical, and independent indicator for predicting the severity and prognosis of MVCD in patients with ACS.
- Open Access
- 7 July 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 944027
Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1
Background: Immunoglobulin A nephropathy (IgAN) is the most common type of primary glomerular disease in adults worldwide. Several studies have reported that galactose-deficient IgA1 (Gd-IgA1) is involved in the pathogenesis of IgAN.Methods: Thirty-five patients with IgAN diagnosed with renal biopsy for the first time served as the experimental group, who were hospitalized in our department. Twenty normal healthy cases in the physical examination center of our hospital served as the control group. Then the levels of Gd-IgA1 in serum and urine, and intestinal mucosal barrier injury indexes [diamine oxidase (DAO), serum soluble intercellular adhesion molecule-1 (sICAM-1), D-lactate (D-LAC), and lipopolysaccharide (LPS)] and inflammatory factors [interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α)] in the serum samples were detected. Fecal samples were collected to detect intestinal microbiota using 16 s rDNA sequencing. Then, we assessed possible correlations among clinical and laboratory findings.Results: In patients with IgAN, the levels of Gd-IgA1 both in the serum and urine were higher than that of the healthy control. Furthermore, urine Gd-IgA1 level was positively correlated with the serum creatinine level, 24 h urine protein, and M, S, and T parameters in the Oxford classification. ROC curve analysis showed that urine Gd-IgA1 has a greater diagnostic value (AUC = 0.9714, 95% CI, 0.932–1; P < 0.0001) for IgAN. The best cutoff value for urine Gd-IgA1 was 0.745 ng·l/ml·μmol (sensitivity, 94%; specificity, 95%). The intestinal mucosal barrier damage indexes (DAO, sICAM-1, D-LAC, and LPS) were increased in the patients with IgAN, which were positively correlated with Gd-IgA1 levels (P < 0.05) both in serum and urine. The levels of inflammatory factors in the patients with IgAN were increased. 16 s rDNA analysis showed that the intestinal microbiota in these patients was disordered compared to that observed in the healthy subjects. Actinobacteria, Bifidobacterium, Blautia, Bifidobacteriaceae, and Bifidobacteriales were decreased and Shigella was increased in IgAN. The decreased populations of these flora were negatively and significantly correlated with urine Gd-IgA1 and the levels of DAO, sICAM-1, D-LAC, and LPS.Conclusion: The urine Gd-IgA1 levels may be a non-invasive biological marker for evaluating kidney injury in IgAN. Gut flora dysbiosis and intestinal barrier dysfunction may be involved in Gd-IgA1 expression.
- 7 July 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 944027
Open AccessGut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1
Background: Immunoglobulin A nephropathy (IgAN) is the most common type of primary glomerular disease in adults worldwide. Several studies have reported that galactose-deficient IgA1 (Gd-IgA1) is involved in the pathogenesis of IgAN.Methods: Thirty-five patients with IgAN diagnosed with renal biopsy for the first time served as the experimental group, who were hospitalized in our department. Twenty normal healthy cases in the physical examination center of our hospital served as the control group. Then the levels of Gd-IgA1 in serum and urine, and intestinal mucosal barrier injury indexes [diamine oxidase (DAO), serum soluble intercellular adhesion molecule-1 (sICAM-1), D-lactate (D-LAC), and lipopolysaccharide (LPS)] and inflammatory factors [interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α)] in the serum samples were detected. Fecal samples were collected to detect intestinal microbiota using 16 s rDNA sequencing. Then, we assessed possible correlations among clinical and laboratory findings.Results: In patients with IgAN, the levels of Gd-IgA1 both in the serum and urine were higher than that of the healthy control. Furthermore, urine Gd-IgA1 level was positively correlated with the serum creatinine level, 24 h urine protein, and M, S, and T parameters in the Oxford classification. ROC curve analysis showed that urine Gd-IgA1 has a greater diagnostic value (AUC = 0.9714, 95% CI, 0.932–1; P < 0.0001) for IgAN. The best cutoff value for urine Gd-IgA1 was 0.745 ng·l/ml·μmol (sensitivity, 94%; specificity, 95%). The intestinal mucosal barrier damage indexes (DAO, sICAM-1, D-LAC, and LPS) were increased in the patients with IgAN, which were positively correlated with Gd-IgA1 levels (P < 0.05) both in serum and urine. The levels of inflammatory factors in the patients with IgAN were increased. 16 s rDNA analysis showed that the intestinal microbiota in these patients was disordered compared to that observed in the healthy subjects. Actinobacteria, Bifidobacterium, Blautia, Bifidobacteriaceae, and Bifidobacteriales were decreased and Shigella was increased in IgAN. The decreased populations of these flora were negatively and significantly correlated with urine Gd-IgA1 and the levels of DAO, sICAM-1, D-LAC, and LPS.Conclusion: The urine Gd-IgA1 levels may be a non-invasive biological marker for evaluating kidney injury in IgAN. Gut flora dysbiosis and intestinal barrier dysfunction may be involved in Gd-IgA1 expression.